Tech entrepreneur Ben Lamm is spearheading Colossal Biosciences, a company aiming to bring back extinct species like the woolly mammoth thr...

Sanjeev Bikhchandani's Info Edge has achieved remarkable capital compounding, deploying Rs 4,900 crore across 135 startups since 2007, now ...

US market saw a mixed close as the S&P 500 and Nasdaq dipped, primarily due to tech giants like Alphabet facing investor scrutiny over AI s...

India must not depend on foreign AI models, as US export controls demonstrate potential access denial. Past reliance on external tech, like...

Info Edge, the parent of Naukri, has significantly boosted its AI and deeptech investments, pouring Rs 1,003 crore into 54 startups since 2...

A gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...

Sunil Singhania's Abakkus Small Cap Fund added three new stocks in May, including Tanla Platforms and Intellect Design Arena. The fund also...

Indian equities lost momentum after a positive start, with Nifty closing lower and broader markets declining sharply. Investor caution ahea...

Concord Biotech's shares surged over 6% after receiving USFDA approval for its Tofacitinib Tablets in 5 mg and 10 mg strengths. This approv...

Indian equities ended higher on Tuesday, supported by easing geopolitical tensions and softer crude prices. A sharp drop in India VIX boost...

America has released a new list of Chinese companies it believes support Beijing's military. Major firms like Alibaba, Baidu, and BYD are i...

Cancer patients in India are struggling to find essential platinum-based drugs. A surge in global platinum prices and supply chain issues a...

British drug giant GSK is reportedly in talks to acquire cancer drugmaker Nuvalent. The deal could be worth over nine billion dollars. Disc...

The U.S. has updated its list of Chinese companies aiding Beijing's military, adding tech giants like Alibaba and Baidu, alongside chipmake...

The Bengaluru-based company makes CAR-T therapy, a form of cancer treatment where a patient’s own immune cells are taken out, trained in a ...

Intel is changing its AI strategy. The company is now focusing on building complete AI systems and infrastructure, not just chips. This mov...

Concord Biotech shares saw a significant jump on Wednesday. This surge followed the company's announcement of receiving approval from the U...